期刊文献+

应用诺和锐30对初诊2型糖尿病患者强化治疗的临床观察 被引量:1

下载PDF
导出
摘要 目的:观察预混双相门冬胰岛素(诺和锐30)对初诊2型糖尿病患者血糖控制及其对胰岛B细胞功能的影响。方法:对138例初诊2型糖病患者,分为诺和锐30治疗组和口服降糖药物治疗组,治疗时间为6个月,检测两组治疗前后空腹及75克葡萄糖负荷后血糖,胰岛素,C肽,糖化血红蛋白等指标,比较两组患者血糖控制情况及胰岛B细胞功能恢复情况。结果:诺和锐30治疗组和口服降糖药物治疗组在降糖,改善胰岛B细胞功能方面,有非常显著差异性。诺和锐30组明显优于口服降糖药物组,血糖达标时间短于口服降糖药物组。结论:对初诊的2型糖尿病人,每日给予二次皮下注射诺和锐30强化治疗能更好的控制血糖,改善和恢复胰岛B细胞功能。
出处 《中国伤残医学》 2008年第1期72-73,共2页 Chinese Journal of Trauma and Disability Medicine
  • 引文网络
  • 相关文献

参考文献7

  • 1[1]Dailey G.New strategies for basal insulin treatment in type 2 diabetes mellitus.Clin Ther,2004,26(6):889-901.
  • 2叶新华,杜云峰,高剑波,薛云,李德,成金罗.短期诺和锐强化治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].中华糖尿病杂志(1006-6187),2005,13(2):114-117. 被引量:87
  • 3祝方,纪立农,韩学尧,朱宇,张红杰,周翔海,陈静,蔡晓陵,张明霞.短期胰岛素强化治疗诱导初诊2型糖尿病患者血糖长期良好控制的临床试验[J].中国糖尿病杂志,2003,11(1):5-9. 被引量:856
  • 4[4]Gammeltoft S,Hanson BF,Dideriksen L,et al.Insulin aspart:a novel rapid acying human insulin analogue.Expert Opin Investing Drugs,199,8:14311442.
  • 5[5]Bohm Bo,Home PD,Behrend C,et al.Premixed insulin aspart 30 Vspremixed human insulin 30/70 twice daily:a randomized trail in type land type 2 diabetic patients.Diabet Med.2002,19:393-399.
  • 6[6]Boehm BO,Home PD,Rastam J,et al.Safety and officacy oflong term exposure to biphasic insulin aspart compared with biphasic human insulin in people with type 2 diabetes.Diabetologia,2003,46(suppl 2):A269.
  • 7[7]Bretzel RG,Amolds S,Medding j,et al.A direct efficacy and safety comparison of insulin aspart,human soluble insulin,and human premix insulin (70/30) in patients with type 2 diabetes.Diabetes Care,2004,27:1023-1027.

二级参考文献12

  • 1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 7Ilkova H,Glaser B,Tunckale A,et al.Induction of long-tem glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care,1997,20:1353-1356.
  • 8Yki-Jarvinen H. Pathogenesis of non-insulin dependent diabetes mellitus. Lancet,1994,343:91-95.
  • 9Elizabeth D,Robertson RP. Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T 15cell line. Diabetes,1998,47:606-611.
  • 10Del Prato S,Marcherri P,Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes,2002,51(Suppl 1):s109-116.

共引文献912

同被引文献27

引证文献1

二级引证文献4

;
使用帮助 返回顶部